Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02468323
Other study ID # Palonosetron01
Secondary ID
Status Completed
Phase Phase 4
First received June 7, 2015
Last updated March 8, 2017
Start date October 2015
Est. completion date February 2017

Study information

Verified date March 2017
Source Hospital de Base
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare the quality of perioperative antiemesis of palonosetron and ondansetron in patients undergoing cesarean section


Description:

Perioperative nausea and vomiting (PONV) related to spinal block anesthesia are common events and unpleasant for pregnant women. Its incidence can reach 80% in high-risk patients, and remains high despite the emergence of new antiemetic drugs.

Episodes untreated can result in prolonged stay in post-anesthetic care unit (PACU) and rehospitalization which can result in significant increase in overall costs of health care.

The purpose of the prophylaxis of PONV is therefore decrease its incidence, the stress of the patient, improve the quality and safety of surgical procedure and reduce hospital costs.

Antagonists of the 5-hydroxytryptamine 3 subtype receptor have been widely used and effective against PONV due to its efficacy and a favorable side-effect profile. Palonosetron is a new and potent drug generation5 second-HT antagonist with improved profile that acts longer. Recent studies where it was compared to ondansetron and palonosetron in high-risk patients in head and neck surgery and laparoscopic surgery is disclosed palonosetron far superior to ondansetron especially 2-24 hours after surgery. But there are no studies on caesareans comparing the two drugs.

This prospective, randomized, double-blind, placebo controlled, was designed to evaluate the efficacy of palonosetron compared with ondansetron and placebo for the prevention of nausea and vomiting in patients undergoing cesarean delivery under spinal anesthesia.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- American Society of Anesthesiologists class I or II

- Scheduled for cesarean section on Maternal and Child Hospital of Brasilia, Federal District, Brazil

Exclusion Criteria:

- patients who had received antiemetics, diabetic, allergic to any study drug, corticosteroid use, psychoactive drugs, patients with vomiting in the course of gastrointestinal disease, eclampsia, heart disease, smokers, any evidence of fetal distress, psychiatric disease or who refused to participate.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Placebo
Patients will receive regular spinal anesthesia
Ondansetron
Patients will receive slow intravenous injection of ondansetron 4 mg after cord clamping
Palonosetron
Patients will receive slow intravenous infection of palonosetron 75 mcg after cord clamping

Locations

Country Name City State
Brazil Hospital de Base do Distrito Federal Brasilia DF

Sponsors (1)

Lead Sponsor Collaborator
Hospital de Base

Country where clinical trial is conducted

Brazil, 

References & Publications (1)

Chattopadhyay S, Goswami S. Palonosetron Versus Ramosetron Prophylaxis for Control of Postoperative Nausea and Vomiting after Cesarean Delivery under Spinal Anesthesia. J Obstet Gynaecol India. 2015 Feb;65(1):28-33. doi: 10.1007/s13224-014-0612-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with nausea and vomiting Within the first 48 hours after surgery
Secondary Nausea Scores on the Number Rating Scale Quantify nausea by Number Rating Scale (NRS, ranging from 0 to 10 cm, zero being found when the patient is no nausea and ten, with maximum or un bearable nausea Within the first 48 hours after surgery
Secondary Nausea Scores on the Verbal Rating Scale Verbal Rating Scale (VRS), consisting of a list of phrases (no nausea, mild nausea, moderate nausea, intense nausea, maximum nausea) Within the first 48 hours after surgery
Secondary Apgar Newborn The resulting Apgar score ranges from zero to 10, measured at first and fifth minute delivery
Secondary Likert Scale Overall satisfaction with the nausea - vomiting experience in a Likert scale of four points (dissatisfied, neutral, satisfied and very satisfied) 48 hours after surgery
Secondary Number of participants with adverse events as a measure of safety and tolerability Intraoperative hemodynamic stability analysis through the incidence of tachycardia, hypertension, bradycardia, hypotension and consumed vasopressors delivery
Secondary Number of participants with adverse events as a measure of safety and tolerability Incidence of adverse effects such as nausea, vomiting, pruritus, urinary retention, drowsiness and consumed rescue antiemetics Within the first 48 hours after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT01945502 - Nasopharyngeal Packing and Rhinologic Surgery. N/A
Completed NCT01840254 - Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial N/A
Completed NCT00772226 - The Use of Music as Pain Therapy in Patients Undergoing Laparoscopic Cholecystectomy in a Day Care Unit Phase 3
Completed NCT00760253 - Compare the Side Effects and Difference Awake Level of Three TCI Propofol Formula in TVOR Patients N/A
Recruiting NCT03783182 - Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy Phase 4
Recruiting NCT03835234 - Incidence and Factors Associated With PONV in Regional Anaesthesia
Recruiting NCT04191694 - Chewing Gum to Prevent Nausea and Vomiting After Caesarean Section Under Spinal Anaesthesia N/A
Recruiting NCT05596695 - Minimisation of Blood Pressure Variability and Postoperative Nausea and Vomiting N/A
Recruiting NCT04570592 - Granisetron vs Granisetron and Dexamethasone on the Reduction of Postoperative Nausea and Vomiting Phase 2
Completed NCT02116257 - The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV N/A
Not yet recruiting NCT05396716 - Acupoint Stimulation Alleviates Postoperative Nausea and Vomiting N/A
Active, not recruiting NCT00892996 - Efficacy of Prevention for Postoperative Nausea and Vomiting After Intrathecal Morphine in Cesarean Section N/A
Recruiting NCT04866121 - Acupuncture for Prevention of Postoperative Nausea and Vomiting N/A
Completed NCT02809378 - The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV Phase 4
Completed NCT05408676 - Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery N/A
Completed NCT01991821 - European Phase III Study of APD421 in PONV Phase 3
Completed NCT00952133 - Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONV Phase 4
Completed NCT04054479 - Penehyclidine for PONV Prophylaxis After Strabismus Surgery Phase 4
Completed NCT05540236 - Effects of Auricular Acupressure on the Management of Postoperative Nausea and Vomiting After Gynecological Laparoscopic Surgeries N/A
Completed NCT03278522 - Ramosetron Pre-treatment for PONV and QT Prolongation Phase 4